首页> 外文期刊>International Journal of Molecular Sciences >Stress-Induced Phosphorylation of Nuclear YB-1 Depends on Nuclear Trafficking of p90 Ribosomal S6 Kinase
【24h】

Stress-Induced Phosphorylation of Nuclear YB-1 Depends on Nuclear Trafficking of p90 Ribosomal S6 Kinase

机译:应激诱导的核YB-1磷酸化取决于p90核糖体S6激酶的核贩运。

获取原文
           

摘要

Ionizing radiation (IR) and epidermal growth factor (EGF) stimulate Y-box binding protein-1 (YB-1) phosphorylation at Ser-102 in KRAS wild-type (KRASwt) cells, whereas in KRAS mutated (KRASmut) cells, YB-1 is constitutively phosphorylated, independent of IR or EGF. YB-1 activity stimulates the repair of IR-induced DNA double-strand breaks (DSBs) in the nucleus. Thus far, the YB-1 nuclear translocation pattern after cell exposure to various cellular stressors is not clear. In the present study, we investigated the pattern of YB-1 phosphorylation and its possible translocation to the nucleus in KRASwt cells after exposure to IR, EGF treatment, and conditional expression of mutated KRAS(G12V). IR, EGF, and conditional KRAS(G12V) expression induced YB-1 phosphorylation in both the cytoplasmic and nuclear fractions of KRASwt cells. None of the stimuli induced YB-1 nuclear translocation, while p90 ribosomal s6 kinase (RSK) translocation was enhanced in KRASwt cells after any of the stimuli. EGF-induced RSK translocation to the nucleus and nuclear YB-1 phosphorylation were completely blocked by the EGF receptor kinase inhibitor erlotinib. Likewise, RSK inhibition blocked RSK nuclear translocation and nuclear YB-1 phosphorylation after irradiation and KRAS(G12V) overexpression. In summary, acute stimulation of YB-1 phosphorylation does not lead to YB-1 translocation from the cytoplasm to the nucleus. Rather, irradiation, EGF treatment, or KRAS(G12V) overexpression induces RSK activation, leading to its translocation to the nucleus, where it activates already-existing nuclear YB-1. Our novel finding illuminates the signaling pathways involved in nuclear YB-1 phosphorylation and provides a rationale for designing appropriate targeting strategies to block YB-1 in oncology as well as in radiation oncology.
机译:电离辐射(IR)和表皮生长因子(EGF)刺激KRAS野生型(KRASwt)细胞中Ser-102处的Y-box结合蛋白1(YB-1)磷酸化,而在KRAS突变(KRASmut)细胞中,YB -1被组成性磷酸化,独立于IR或EGF。 YB-1活性刺激了核中IR诱导的DNA双链断裂(DSB)的修复。到目前为止,尚不清楚细胞暴露于各种细胞应激源后的YB-1核易位模式。在本研究中,我们研究了YB-1磷酸化的模式及其在IR,EGF处理和突变KRAS(G12V)的条件表达后可能在KRASwt细胞中转移到核中的可能。 IR,EGF和条件性KRAS(G12V)表达诱导KRASwt细胞的细胞质和核级分中的YB-1磷酸化。刺激均未诱导YB-1核易位,而任何刺激后KRASwt细胞中p90核糖体s6激酶(RSK)易位均得到增强。 EGF受体激酶抑制剂厄洛替尼完全阻断了EGF诱导的RSK易位至核和核YB-1磷酸化。同样,在辐射和KRAS(G12V)过表达后,RSK抑制也阻止了RSK核移位和核YB-1磷酸化。总之,YB-1磷酸化的急性刺激不会导致YB-1从细胞质转移到细胞核。而是,辐射,EGF处理或KRAS(G12V)过表达诱导RSK活化,从而导致RSK易位至细胞核,从而活化已经存在的核YB-1。我们的新发现阐明了涉及核YB-1磷酸化的信号通路,并为设计适当的靶向策略以在肿瘤学和放射肿瘤学中阻断YB-1提供了理论依据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号